HSIC — Henry Schein Share Price
0.000.00%
Last trade - 00:00- $7.93bn
- $11.79bn
- $12.67bn
- 94
- 71
- 71
- 93
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.95 | ||
| PEG Ratio (f) | 0.75 | ||
| EPS Growth (f) | 21.01% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.34 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 12 | ||
| Price to Sales | 0.63 | ||
| EV to EBITDA | 12.84 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 8.37% | ||
| Return on Equity | 11.07% | ||
| Operating Margin | 4.9% | ||
Financial Summary
| Year End 28th Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 10,119.14 | 12,401.02 | 12,647 | 12,339 | 12,673 | 13,004.15 | 13,476.28 | 4.88% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -34.22 | +44.51 | +7.05 | -19.25 | -2.96 | +27.89 | +8.86 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Henry Schein, Inc. is a solutions company for healthcare professionals. Its segments consist of Global Distribution and Value-Added services, Global Specialty Services, and Global Technology. Global Distribution and Value-Added Services include the distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting and other services. This segment also markets and sells under its own brand, a portfolio of consumable merchandise. The Global Specialty Products includes the manufacturing, marketing and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other healthcare-related products and services. Global Technology includes the development and distribution of practice management software, e-services, and other products.
Directors
- Stanley Bergman CHM (71)
- James Breslawski PRE (67)
- Steven Paladino CFO (64)
- David Brous CEX (52)
- Brad Connett CEX (62)
- Rene Willi CEX (53)
- Lorelei McGlynn CHO (57)
- Gerald Benjamin EVP (68)
- Mark Mlotek EVP (65)
- Christopher Pendergast SVP (58)
- Kelly Murphy SVP
- Michael Ettinger SVP (59)
- Jonathan Koch SVP (46)
- James Mullins SVP (56)
- Michael Racioppi SVP (66)
- Walter Siegel OTH (61)
- Jennifer Ferrero SEC
- Philip Laskawy LED (79)
- Scott Serota DRC
- Mohamad Ali IND (50)
- Barry Alperin IND (80)
- Deborah Derby IND (57)
- Joseph Herring IND (65)
- Kurt Kuehn IND (66)
- Anne Margulies IND (65)
- Carol Raphael IND (78)
- Elizabeth Rekow IND (76)
- Bradley Sheares IND (63)
- Last Annual
- December 28th, 2024
- Last Interim
- December 28th, 2024
- Incorporated
- December 23rd, 1992
- Public Since
- November 3rd, 1995
- No. of Shareholders
- 108,000
- No. of Employees
- 25,000
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 122,511,948
- Address
- 135 Duryea Rd, MELVILLE, 11747
- Web
- https://www.henryschein.com/
- Phone
- +1 6318435500
- Contact
- Graham Stanley
- Auditors
- BDO USA, P.C.
Upcoming Events for HSIC
Q1 2025 Henry Schein Inc Earnings Release
Henry Schein Inc Annual Shareholders Meeting
Henry Schein Inc Annual Shareholders Meeting
Q2 2025 Henry Schein Inc Earnings Release
Similar to HSIC
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Henry Schein share price?
As of Today at 21:04 UTC, shares in Henry Schein are trading at $64.73. This share price information is delayed by 15 minutes.
How has the Henry Schein share price performed this year?
Shares in Henry Schein last closed at $64.73 and the price had moved by -7.79% over the past 365 days. In terms of relative price strength the Henry Schein share price has underperformed the S&P500 Index by -13.3% over the past year.
What are the analyst and broker recommendations for Henry Schein?
The overall consensus recommendation for Henry Schein is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Henry Schein dividend yield?
Henry Schein does not currently pay a dividend.
Does Henry Schein pay a dividend?
Henry Schein does not currently pay a dividend.
When does Henry Schein next pay dividends?
Henry Schein does not currently pay a dividend.
How do I buy Henry Schein shares?
To buy shares in Henry Schein you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Henry Schein?
As of the previous close price of $64.73, shares in Henry Schein had a market capitalisation of $7.93bn.
Where are Henry Schein shares listed?
Here are the trading details for Henry Schein:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: HSIC
What kind of share is Henry Schein?
Based on an overall assessment of its quality, value and momentum Henry Schein is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Henry Schein share price forecast for 2025?
The analyst consensus target price for shares in Henry Schein is $78.57. That is 21.38% above the last closing price of $64.73.
Analysts covering Henry Schein currently have a consensus Earnings Per Share (EPS) forecast of $4.87 for the next financial year.
Find out moreWhat is the trend in the Henry Schein share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Henry Schein. Over the past six months, its share price has underperformed the S&P500 Index by -0.91%.
As of the last closing price of $64.73, shares in Henry Schein were trading -9.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Henry Schein PE Ratio?
The Henry Schein PE ratio based on its reported earnings over the past 12 months is 12.95. The shares last closed at $64.73.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Henry Schein?
Henry Schein's management team is headed by:
- Stanley Bergman - CHM
- James Breslawski - PRE
- Steven Paladino - CFO
- David Brous - CEX
- Brad Connett - CEX
- Rene Willi - CEX
- Lorelei McGlynn - CHO
- Gerald Benjamin - EVP
- Mark Mlotek - EVP
- Christopher Pendergast - SVP
- Kelly Murphy - SVP
- Michael Ettinger - SVP
- Jonathan Koch - SVP
- James Mullins - SVP
- Michael Racioppi - SVP
- Walter Siegel - OTH
- Jennifer Ferrero - SEC
- Philip Laskawy - LED
- Scott Serota - DRC
- Mohamad Ali - IND
- Barry Alperin - IND
- Deborah Derby - IND
- Joseph Herring - IND
- Kurt Kuehn - IND
- Anne Margulies - IND
- Carol Raphael - IND
- Elizabeth Rekow - IND
- Bradley Sheares - IND